DOI : 10.1055/s-00000034

Klinische Pädiatrie

Ausgabe 03 · Volume 230 · Mai 2018 DOI: 10.1055/s-008-39721

Kind-Philipp-Stiftung für pädiatrisch-onkologische Forschung
31. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung
Wilsede, Lüneburger Heide, 06.–09.06.2018

Wissenschaftliche Leitung: Prof. Dr. Martin Horstmann Prof. Dr. Martin Stanulla Prof. Dr. Rolf Marschalek Prof. Dr. Olaf Heidenreich
Abstracts (HTML) Autorenliste
1
Miroshnichenkova, A; Komkov, A; Zerkalenkova, E; Mamedov, I; Olshanskaya, Y: Comparison of NGS and RT-PCR approaches for MRD monitoring in acute lymphoblastic leukemia
2
Olk, N; Gauert, A; Eckert, C; Heeren-Hagemann, A: Human-zebrafish xenograft platform to individualise therapy for acute lymphoblastic leukaemia patients (ALL-ZeFiX)
3
Isa, A; Martinez-Soria, N; McKenzie, L; Blair, H; Issa, H; Luli, S; Nakjang, S; Heidenreich, O: Identification of glycolytic pathway as RUNX1/ETO-dependent for propagation and survival
4
Kontopoulou, E; Neuhoff, N von; Giebel, B; Reinhardt, D; Thakur, BK: Evaluation of dsDNA from extracellular vesicles (EVs) as biomarker in pediatric AML
5
Kunz, F; Kontopoulou, E; Giebel, B; Neuhoff von, N; Reinhardt, D; Thakur, BK: Biomarker potential of mRNA in extracellular vesicles in pediatric AML
6
Verboon, L; Schneider, D; Xu, J; Heckl, D; Klusmann, JH: Deciphering the genetically interactive network of the DLK1-DIO3 ncRNA locus in the hematopoietic system and pediatric acute megakaryoblastic leukemia
7
Labuhn, M; Perkins, K; Papaemmanuil, E; Scheer, C; Weiss, MJ; Campbell, PJ; Crispino, JD; Taub, JW; Heckl, D; Klusmann, JH; Vyas, P: Modelling the progression of a preleukemic stage to overt leukemia in children with Down syndrome
8
Beckett, M; Shi, Y; Blair, H; Krippner-Heidenreich, A; van Delft, F: In vitro and in vivo genome wide CRISPR screening under drug treatment in T-ALL
9
Ng, M; Emmrich, S; Schwarzer, A; Heckl, D; Klusmann, JH: CRISPRi screening to identify functional long noncoding RNAs in pediatric acute myeloid leukemia
10
Kroll, M; Bleckmann, K; Möricke, A; Schewe, D; Cario, G; Schrappe, M: Methotrexate-associated toxicity during therapy of acute lymphoblastic leukemia in children with Down syndrome
11
Alejo, O; Labuhn, M; Emmrich, S; Heckl, D; Klusmann, JH: Cooperativity between miR-125b and Gata1 s in the pathogenesis of Down syndrome-associated myeloid leukemia
12
Bhayadia, R; Heckl, D; Klusmann, JH: Patient-derived xenografts for pre-clinical drug development in AML
13
Cantilena, S; Marteens, JHA; Heidenreich, O; Klussman, JH; Williams, O; de Boer, J: Redeployed drug inducing MLL fusion degradation
14
Kadel, S; Gialesaki, S; Knoess, S; Heckl, D; Klusmann, JH: Functional and molecular characterization of oncogenic dependencies on chromosome 21 in Down syndrome-associated myeloid leukemia
15
Wirbelauer, T; Alsadeq, A; Lenk, L; Vossen-Gajcy, M; Cario, G; Schrappe, M; Schewe, DM: Chemokine receptor expression in central nervous system (CNS) positive childhood acute lymphoblastic leukemia
16
Law, E; McKenzie, L; Szoltysek, K; Lunec, J; Irving, J; Vormoor, J; Heidenreich, O: Investigating novel drug combinations against patient-derived xenografts of acute lymphoblastic leukaemia
17
Issa, H; Blair, H; Dal Porto, A; Jyotsana, N; Heuser, M; Heidenreich, O: Therapeutic targeting of the leukaemic fusion gene RUNX1/ETO